About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli ...

Eli Lilly is now offering four doses of Zepbound in self-administration vials. The lower-cost self-pay option targets people ...

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...

Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Eli Lilly and Co.

New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...

Eli Lilly announced plans Wednesday to invest at least $27 billion in building four new manufacturing plants in the United ...

Eli Lilly plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the drugmaker said at a ...

Medicare spending on some diabetes drugs, including popular treatments such as Ozempic, surged nearly five-fold to $35.8 ...

The new lower prices apply to some doses of Zepbound provided in vials but not the autoinjector pens.

Whales with a lot of money to spend have taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli ...

The end of the official shortage status for semaglutide came as telehealth company Hims & Hers – which has been pushing sales ...